drugset / Trial / NCT01843556

A Phase 1 Study of E2022 Tape Formulation for Different Application Sites and Intervals in Japanese Healthy Elderly Males

NCT01843556

Phase 1 Completed 48 enrolled Eisai Inc.
Non-randomizedSingle-groupOpen-labelTreatment

Summary

A phase 1 study of E2022 tape formulation in healthy elderly males to evaluate the safety and pharmacokinetics.

Timeline

Start
2012-12
Primary completion
2013-04
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Donepezil Small molecule Topical

Indications

No indication recorded.